Prescription Audits: When the DEA or AG Come Knocking
Anticipating and Responding to Heightened Investigations of Prescribing and Dispensing Practices
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will discuss the increased scrutiny of healthcare providers’ prescribing and dispensing practices by the Drug Enforcement Administration (DEA) and state attorneys general (AG) through their medical boards and other actions, and will guide counsel in preparing for and responding to prescription audits and ensuring ongoing regulatory compliance.
- Current trends in prescribing and dispensing enforcement
- Audit process
- State AG
- Audit preparedness
- Maintaining records
- Policies and procedures
- Risk issues
- Responding to an audit
The panel will review these and other crucial issues:
- What should providers and counsel expect when the DEA or state AG conducts a prescription audit?
- What policies and procedures should be in place to ensure compliance with federal regulations?
- What are best practices for counsel to providers facing a DEA or state AG audit?
Lindsay P. Holmes
Ms. Holmes focuses her practice on regulatory and transactional matters primarily in the healthcare and life sciences... | Read More
Ms. Holmes focuses her practice on regulatory and transactional matters primarily in the healthcare and life sciences industries. She has experience advising clients on FDA regulatory matters including drug, device, dietary supplement and cosmetic issues, as well as matters related to 503B outsourcing facilities and the Drug Quality and Security Act. Ms. Holmes also helps pharmacy clients navigate state licensing and pharmacy practice act issues. Additionally, she has experience counseling clients on data privacy and security matters, fraud and abuse, and Medicare Part D.Close
Ms. Mazina offers extensive experience to healthcare providers in the areas of government investigations, including... | Read More
Ms. Mazina offers extensive experience to healthcare providers in the areas of government investigations, including DEA, FDA, HHS, boards of pharmacy and medical boards; third-party audits and licensing involving PBMs, Medicaid, and Medicare; compliance with board of pharmacy, medical board, FDA and DEA regulations, PBM contracts and manuals, HIPAA and state privacy laws, and Anti-Kickback Statutes and false claims; as well as license defense. She is a frequent author and lecturer on minimizing risk in relation to controlled substances, among other matters.Close
Dennis A. Wichern
Prescription Drug Consulting
Mr. Wichern is a 30-year veteran of the DEA who formerly managed the Chicago Field Division. He currently assists... | Read More
Mr. Wichern is a 30-year veteran of the DEA who formerly managed the Chicago Field Division. He currently assists healthcare providers in navigating through the myriad of federal laws and regulations concerning prescription drugs. Mr. Wichern is a recognized expert on the dangers of the prescription drug epidemic and routinely speaks to healthcare providers to identify methods to better safeguard their practices and reduce the professional and operational risks emanating from these threats. He was the first to develop CME and CLE programs addressing MAT and pain prescribing safeguards, federal regulatory and DEA compliance, and drug destruction.Close